DHR vs IDXX
Danaher Corporation vs Idexx Laboratories — AI-powered side-by-side comparison
DHR
Danaher Corporation
63
Buy
VS
IDXX
Idexx Laboratories
62
Buy
| Metric | DHR | IDXX |
|---|
| AI Score |
63
|
62
|
| Price |
$204.80
|
$586.77
|
| P/E Ratio |
36.24×
|
41.20×
|
| ROE |
6.9%
|
66.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
58.5%
|
62.4%
|
| Debt / Equity |
0.51×
|
0.60×
|
| Dividend Yield |
0.7%
|
0.0%
|
| RSI (14) |
67.2
|
65.3
|
| Beta |
0.823
|
1.549
|
| Expected Upside |
+1.6%
|
+12.3%
|
AI Committee View
Current Innellis committee reasoning for DHR versus IDXX.
DHR leads by 1 points.
DHR scores 63/100 (Buy) versus IDXX at 62/100 (Buy).
DHR Committee View
80% agreement
5 analysts
The primary driver is market regime is bullish (bull market -- normal position sizing). The main limiting factor is p/e of 35.9 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 35.9 is moderate-to-rich — Value
IDXX Committee View
60% agreement
5 analysts
Positive signals support the current rating — 5 consecutive earnings beats -- consistent execution. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- ROE of 72.0% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- P/E of 40.6 is expensive by classic value standards — Value
- Price-to-book of 33.7x prices in significant intangible value — Value